comparemela.com

Page 4 - தொடர்பில் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why Teladoc Stock Jumped 10 4% in June

What happened Shares of telehealth leader Teladoc Health (NYSE:TDOC) rose 10.4% in June, according to data from S&P Global Market Intelligence. This pop was probably due to some investors believing the market s sell-off of the stock this year has been overkill and presents an attractive buying opportunity. For context, the S&P 500 returned 2.3% last month. Even with June s gain, in 2021, shares of Teladoc are down 17.8% through Thursday, July 1. Last year, the large-cap stock (a stock with market cap of $10 billion or more) was up a whopping 139%, led by the company s pandemic-driven surge in new business. Image source: Getty Images.

Tele Intensive Care Unit Market - Growth, Trends, COVID-19

Tele Intensive Care Unit Market - Growth, Trends, COVID-19
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

How telehealth enabled critical care for newborns during COVID-19

How telehealth enabled critical care for newborns during COVID-19
healthcareitnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcareitnews.com Daily Mail and Mail on Sunday newspapers.

Why Teladoc Stock Fell 13% in May | The Motley Fool

What happened Shares of telehealth leader Teladoc Health (NYSE:TDOC) fell 12.6% in May, according to data from S&P Global Market Intelligence. The prime catalyst behind the decline was the company s release of first-quarter results in late April that disappointed some investors. For context, the S&P 500 returned 0.7% last month. In 2021, shares of Teladoc are struggling. They re down 26.6% through Friday, June 4, while the broader market has returned 13.4% over this period. (A stock chart follows.) In 2020, the stock gained 139%, thanks to a brisk tailwind from the COVID-19 pandemic. That performance made it one of the year s best-performing large-cap stocks, which are stocks with market caps of at least $10 billion.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.